Rheumatology in East Setauket, NY
3 verified rheumatology doctors in East Setauket.
Rheumatologists treat autoimmune and inflammatory conditions affecting the joints, muscles, and connective tissue.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New York State Board for Professional Medical Conduct
Dr. Qingping Yao, MD
Rheumatology
CMS Open Payments· $25.49 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$25.49
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 6,451 rheumatology doctors we've analyzed, about 56% received any industry payment (median $958 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US rheumatology doctors.
Payments to Qingping Yao do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Qing Metzger, DO
Rheumatology
CMS Open Payments· $207.63 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$207.63
Total received
4
Transactions
2
Paying companies
Top paying companies
Among the 6,451 rheumatology doctors we've analyzed, about 56% received any industry payment (median $958 among those who did). This doctor's total ranks around the 59th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US rheumatology doctors.
Payments to Qing Metzger do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ayse Bag Ozbek, MD
Rheumatology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.